β-Catenin activation drives thymoma initiation and progression in mice

Oncotarget

Volumn 6, Issue 16, 2015, Pages 13978-13993

  Liang, Chih Chia ^a   Lu, Tsai Ling ^a   Yu, Yi Ru ^a   You, Li Ru ^a   Chen, Chun Ming ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b Taiwan Mouse Clinic National Phenotyping Center   (Taiwan)

Author keywords

AIRE; Cytokeratin 5; P63; 5t; Thymic epithelium; Thymus

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; BETA CATENIN; CYTOKERATIN 5; ESTROGEN RECEPTOR; PROTEIN P63; TAMOXIFEN; WNT PROTEIN; CTNNB1 PROTEIN, MOUSE;

ADULT; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; LIGAND BINDING; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; THYMOMA; TUMOR GROWTH; ANIMAL; BOVINE; C57BL MOUSE; DISEASE COURSE; GENETICS; HUMAN; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; CATTLE; DISEASE PROGRESSION; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; TAMOXIFEN; THYMOMA; WNT SIGNALING PATHWAY;

EID: 84931077921     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4368     Document Type: Article

References (60)

1. Anderson G and Takahama Y. Thymic epithelial cells: working class heroes for T cell development and repertoire selection. Trends Immunol. 2012; 33:256-263.
2. Shezen E, Okon E, Ben-Hur H and Abramsky O. Cytokeratin expression in human thymus: immunohistochemical mapping. Cell Tissue Res. 1995; 279:221-231.
3. Klug DB, Carter C, Crouch E, Roop D, Conti CJ and Richie ER. Interdependence of cortical thymic epithelial cell differentiation and T-lineage commitment. Proc Natl Acad Sci USA. 1998; 95:11822-11827.
4. Gill J, Malin M, Hollander GA and Boyd R. Generation of a complete thymic microenvironment by MTS24(+) thymic epithelial cells. Nat Immunol. 2002; 3:635-642.
5. Lomada D, Liu B, Coghlan L, Hu Y and Richie ER. Thymus Medulla Formation and Central Tolerance Are Restored in IKKα-/- Mice That Express an IKKα Transgene in Keratin 5+ Thymic Epithelial Cells. J Immunol. 2007; 178:829-837.
6. Liang C-C, You L-R, Yen JJ-Y, Liao N-S, Yang-Yen H-F and Chen C-M. Thymic epithelial beta-catenin is required for adult thymic homeostasis and function. Immunol Cell Biol. 2013; 91:511-523.
7. Dooley J, Erickson M and Farr AG. Alterations of the Medullary Epithelial Compartment in the Aire-Deficient Thymus: Implications for Programs of Thymic Epithelial Differentiation. J Immunol. 2008; 181:5225-5232.
8. Heino M, Peterson P, Sillanpää N, Guérin S, Wu L, Anderson G, Scott HS, Antonarakis SE, Kudoh J, Shimizu N, Jenkinson EJ, Naquet P and Krohn KJE. RNA and protein expression of the murine autoimmune regulator gene (Aire) in normal, RelB-deficient and in NOD mouse. Eur J Immunol. 2000; 30:1884-1893.
9. Heino M, Peterson P, Kudoh J, Nagamine K, Lagerstedt A, Ovod V, Ranki A, Rantala I, Nieminen M, Tuukkanen J, Scott HS, Antonarakis SE, Shimizu N and Krohn K. Autoimmune Regulator Is Expressed in the Cells Regulating Immune Tolerance in Thymus Medulla. Biochem Biophys Res Commun. 1999; 257:821-825.
10. Nishikawa Y, Hirota F, Yano M, Kitajima H, Miyazaki J-i, Kawamoto H, Mouri Y and Matsumoto M. Biphasic Aire expression in early embryos and in medullary thymic epithelial cells before end-stage terminal differentiation. J Exp Med. 2010; 207:963-971.
11. Fletcher AL, Lowen TE, Sakkal S, Reiseger JJ, Hammett MV, Seach N, Scott HS, Boyd RL and Chidgey AP. Ablation and Regeneration of Tolerance-Inducing Medullary Thymic Epithelial Cells after Cyclosporine, Cyclophosphamide, and Dexamethasone Treatment. J Immunol. 2009; 183:823-831.
12. Jenkinson WE, Nakamura K, White AJ, Jenkinson EJ and Anderson G. Normal T cell selection occurs in CD205-deficient thymic microenvironments. PLoS ONE. 2012; 7:e53416.
13. Hamazaki Y, Fujita H, Kobayashi T, Choi Y, Scott HS, Matsumoto M and Minato N. Medullary thymic epithelial cells expressing Aire represent a unique lineage derived from cells expressing claudin. Nat Immunol. 2007; 8:304-311.
14. Yang SJ, Ahn S, Park CS, Holmes KL, Westrup J, Chang CH and Kim MG. The quantitative assessment of MHC II on thymic epithelium: implications in cortical thymocyte development. Int Immunol. 2006; 18:729-739.
15. Akiyama T, Maeda S, Yamane S, Ogino K, Kasai M, Kajiura F, Matsumoto M and Inoue J-i. Dependence of Self- Tolerance on TRAF6-Directed Development of Thymic Stroma. Science 2005; 308:248-251.
16. Ripen AM, Nitta T, Murata S, Tanaka K and Takahama Y. Ontogeny of thymic cortical epithelial cells expressing the thymoproteasome subunit β5t. Eur J Immunol. 2011; 41:1278-1287.
17. Murata S, Sasaki K, Kishimoto T, Niwa S-i, Hayashi H, Takahama Y and Tanaka K. Regulation of CD8+ T Cell Development by Thymus-Specific Proteasomes. Science 2007; 316:1349-1353.
18. Kelly RJ, Petrini I, Rajan A, Wang Y and Giaccone G. Thymic Malignancies: From Clinical Management to Targeted Therapies. J Clin Oncol. 2011; 29:4820-4827.
19. Engels EA. Epidemiology of thymoma and associated malignancies. J Thorac Oncol. 2010; 5:S260-265.
20. Rosai J. (1999). Histological Typing of Tumors of the Thymus. (Berlin, Germany: Spring-Verlag).
21. Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, Tada H, Eimoto T, Matsuda H and Masaoka A. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma. Cancer. 2002; 94:624-632.
22. Nakagawa K, Asamura H, Matsuno Y, Suzuki K, Kondo H, Maeshima A, Miyaoka E and Tsuchiya R. Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg. 2003; 126:1134-1140.
23. Moran CA, Weissferdt A, Kalhor N, Solis LM, Behrens C, Wistuba, II and Suster S. Thymomas I: a clinicopathologic correlation of 250 cases with emphasis on the World Health Organization schema. Am J Clin Pathol. 2012; 137:444-450.
24. Zhou R, Zettl A, Strobel P, Wagner K, Muller-Hermelink HK, Zhang S, Marx A and Starostik P. Thymic epithelial tumors can develop along two different pathogenetic pathways. Am J Pathol. 2001; 159:1853-1860.
25. Inoue M, Starostik P, Zettl A, Strobel P, Schwarz S, Scaravilli F, Henry K, Willcox N, Muller-Hermelink HK and Marx A. Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas. Cancer Res. 2003; 63:3708-3715.
26. Kuraguchi M, Wang XP, Bronson RT, Rothenberg R, Ohene-Baah NY, Lund JJ, Kucherlapati M, Maas RL and Kucherlapati R. Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. PLoS Genet. 2006; 2:e146.
27. Aoki K and Taketo MM. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene. J Cell Sci. 2007; 120:3327-3335.
28. Zuklys S, Gill J, Keller MP, Hauri-Hohl M, Zhanybekova S, Balciunaite G, Na K-J, Jeker LT, Hafen K, Tsukamoto N, Amagai T, Taketo MM, Krenger W and Holländer GA. Stabilized beta-Catenin in Thymic Epithelial Cells Blocks Thymus Development and Function. J Immunol. 2009; 182:2997-3007.
29. Lo Celso C, Prowse DM and Watt FM. Transient activation of beta-catenin signalling in adult mouse epidermis is sufficient to induce new hair follicles but continuous activation is required to maintain hair follicle tumours. Development 2004; 131:1787-1799.
30. Van Mater D, Kolligs FT, Dlugosz AA and Fearon ER. Transient activation of beta -catenin signaling in cutaneous keratinocytes is sufficient to trigger the active growth phase of the hair cycle in mice. Gene Dev. 2003; 17:1219-1224.
31. Marx A, Hohenberger P, Hoffmann H, Pfannschmidt J, Schnabel P, Hofmann H-S, Wiebe K, Schalke B, Nix W, Gold R, Willcox N, Peterson P and Ströbel P. The Autoimmune Regulator AIRE in Thymoma Biology: Autoimmunity and Beyond. J Thorac Oncol. 2010; 5:S266-S272.
32. Dotto J, Pelosi G and Rosai J. Expression of p63 in thymomas and normal thymus. Am J Clin Pathol. 2007; 127:415-420.
33. Kikuchi T, Ichimiya S, Kojima T, Crisa L, Koshiba S, Tonooka A, Kondo N, Van Der Saag PT, Yokoyama S and Sato N. Expression profiles and functional implications of p53-like transcription factors in thymic epithelial cell subtypes. Int Immunol. 2004; 16:831-841.
34. Chilosi M, Zamo A, Brighenti A, Malpeli G, Montagna L, Piccoli P, Pedron S, Lestani M, Inghirami G, Scarpa A, Doglioni C and Menestrina F. Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours. Virchows Arch. 2003; 443:175-183.
35. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dötsch V, Andrews NC, Caput D and McKeon F. p63, a p53 Homolog at 3q27 29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities. Mol Cell 1998; 2:305-316.
36. Zhang Z, Li W, Cheng S, Yao H, Zhang F, Chang Q, Ke Z, Wang X, Son YO, Luo J and Shi X. Nickel-induced down-regulation of DeltaNp63 and its role in the proliferation of keratinocytes. Toxicol Appl Pharmacol. 2011; 253:235-243.
37. Westfall MD, Mays DJ, Sniezek JC and Pietenpol JA. The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol Cell Biol. 2003; 23:2264-2276.
38. King KE, Ponnamperuma RM, Allen C, Lu H, Duggal P, Chen Z, Van Waes C and Weinberg WC. The p53 homologue DeltaNp63alpha interacts with the nuclear factor-kappaB pathway to modulate epithelial cell growth. Cancer Res. 2008; 68:5122-5131.
39. Petitjean A, Ruptier C, Tribollet V, Hautefeuille A, Chardon F, Cavard C, Puisieux A, Hainaut P and Caron de Fromentel C. Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with deltaNp73. Carcinogenesis. 2008; 29:273-281.
40. Baldi A, Ambrogi V, Mineo D, Mellone P, Campioni M, Citro G and Mineo TC. Analysis of cell cycle regulator proteins in encapsulated thymomas. Clin Cancer Res. 2005; 11:5078-5083.
41. Ripen AM, Nitta T, Murata S, Tanaka K and Takahama Y. Ontogeny of thymic cortical epithelial cells expressing the thymoproteasome subunit beta5t. Eur J Immunol. 2011; 41:1278-1287.
42. Takahama Y, Takada K, Murata S and Tanaka K. beta5t-containing thymoproteasome: specific expression in thymic cortical epithelial cells and role in positive selection of CD8+ T cells. Curr Opin Immunol. 2012; 24:92-98.
43. Yamada Y, Tomaru U, Ishizu A, Kiuchi T, Marukawa K, Matsuno Y and Kasahara M. Expression of proteasome subunit beta5t in thymic epithelial tumors. Am J Surg Pathol. 2011; 35:1296-1304.
44. Hayashi A, Fumon T, Miki Y, Sato H, Yoshino T and Takahashi K. The evaluation of immunohistochemical markers and thymic cortical microenvironmental cells in distinguishing thymic carcinoma from type b3 thymoma or lung squamous cell carcinoma. J Clin Exp Hematop. 2013; 53:9-19.
45. Bickenbach JR, Greer JM, Bundman DS, Rothnagel JA and Roop DR. Loricrin expression is coordinated with other epidermal proteins and the appearance of lipid lamellar granules in development. J Invest Dermatol. 1995; 104:405-410.
46. Mehrel T, Hohl D, Rothnagel JA, Longley MA, Bundman D, Cheng C, Lichti U, Bisher ME, Steven AC, Steinert PM and et al. Identification of a major keratinocyte cell envelope protein, loricrin. Cell. 1990; 61:1103-1112.
47. Strobel P, Hohenberger P and Marx A. Thymoma and thymic carcinoma: molecular pathology and targeted therapy. J Thorac Oncol. 2010; 5:S286-290.
48. Park W-Y, Kimb J-I, Shim E-H, Lee W-H, Kim S-H, Seo J-W, Jang J-J and Seoab J-S. Development of thymic carcinoma in transgenic mice expressing SV40 T antigen. Cancer Lett. 1996; 107:293-300.
49. Carraresi L, Tripodi SA, Mulder LC, Bertini S, Nuti S, Schuerfeld K, Cintorino M, Bensi G, Rossini M and Mora M. Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes. Oncogene. 2001; 20:8148-8153.
50. Weinberg RA. (2007). The biology of cancer. (New York: Garland Science, Taylor and Francis Group).
51. Harbour JW, Luo RX, Santi AD, Postigo AA and Dean DC. Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1. Cell. 1999; 98:859-869.
52. Scheijen B, Bronk M, van der Meer T, De Jong D and Bernards R. High Incidence of Thymic Epithelial Tumors in E2F2 Transgenic Mice. J Biol Chem. 2004; 279:10476-10483.
53. Moriyama A, Kii I, Sunabori T, Kurihara S, Takayama I, Shimazaki M, Tanabe H, Oginuma M, Fukayama M, Matsuzaki Y, Saga Y and Kudo A. GFP transgenic mice reveal active canonical Wnt signal in neonatal brain and in adult liver and spleen. Genesis. 2007; 45:90-100.
54. Liang C-C, You LR, Chang J-L, Tsai T-F and Chen C-M. Transgenic mice exhibiting inducible and spontaneous Cre activities driven by a bovine keratin 5 promoter that can be used for the conditional analysis of basal epithelial cells in multiple organs. J Biomed Sci. 2009; 16:2.
55. Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, Sommer L, Boussadia O and Kemler R. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 2001; 128:1253-1264.
56. Lu T-L, Huang Y-F, You L-R, Chao N-C, Su F-Y, Chang J-L and Chen C-M. Conditionally Ablated Pten in Prostate Basal Cells Promotes Basal-to-Luminal Differentiation and Causes Invasive Prostate Cancer in Mice. Am J Pathol. 2013; 182:975-991.
57. Chen C-M and Behringer RR. Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis. Gene Dev. 2004; 18:320-332.
58. Lu T-L, Chang J-L, Liang C-C, You L-R and Chen C-M. Tumor Spectrum, Tumor Latency and Tumor Incidence of the Pten-Deficient Mice. PLoS ONE. 2007; 2:e1237.
59. Chen C-M, Wang H-Y, You L-R, Shang R-L and Liu F-C. Expression analysis of an evolutionary conserved metallophosphodiesterase gene, Mpped1, in the normal and beta-catenin-deficient malformed dorsal telencephalon. Dev Dyn. 2010; 239:1797-1806.
60. Lu T-L and Chen C-M. Differential Requirements for β-Catenin in Murine Prostate Cancer Originating from Basal versus Luminal Cells. J Pathol. 2015; 236:290-301.